Tilray Brands fell after reporting another weak quarter for the period ending in August.
The Canadian cannabis stock had rallied on hopes the U.S. would finally legalized weed.
The stock isn't the best way to play U.S. legalization with a whole host of smaller U.S. MSOs the ones likely to see the biggest gains.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments